课题基金 / 基金详情

Relaxin signalling in the endometrium and the regulation of early pregnancy

Relaxin signalling in the endometrium and the regulation of early pregnancy
子宫内膜松弛素信号传导及早期妊娠的调节
批准号:
nhmrc : 349502
负责人:
Prof Richard Ivell
金额:
$31.08万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2005
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2005-01-01 至 2007-12-31

项目摘要

项目成果

Prof Richard Ivell的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Relaxin is a hormone, that is made in the ovary and the uterus, and plays a very important role in supporting the growth and development of the uterus so that the young embryo can implant properly. In fact, early pregnancy loss is associated with altered levels of relaxin in the blood. Very little is known about how relaxin works in the uterus. This project aims to address this important function, and makes use of cultured uterine cells prepared from tissues taken from women undergoing hysterectomy for fibroids or similar illnesses. When these cells are grown in culture, we can mimic in vitro many of the events that occur in early pregnancy, causing the cells to differentiate and grow just as they would in vivo. Relaxin appears to exert its important effects on these cells by causing the concentration of the second messenger cAMP in the so-called stromal cells to increase greatly and in a sustained manner. It is this cAMP which is then responsible for many of the changes which are essential for healthy pregnancy. A knowledge of the molecular mechanisms behind these effects would help us firstly to understand how the uterus becomes receptive to an implanting embryo, and may explain why some women lose their babies in early pregnancy, or develop some of the negative symptoms associated with placental development such as growth restriction and preeclampsia. Relaxin appears to stimulate cells through the mediation of a new type of cell surface receptor, called LGR7. Whilst structurally this receptor looks like those for many other hormones, belonging to the group of so-called G-protein coupled receptors, it does not behave like these in natural uterine cells. Instead it appears to make use of completely new signaling pathways inside the cells. This project aims to unravel and understand these new pathways, thus providing information not only of importance for diagnosis and treatment of early pregnancy problems, but also of relevance for all other similar receptors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Non-classical steroid signalling through SF-1 responsive genes: a key mechanism in environmental endocrine disruption, cancer, and aging
  • 批准号:
    DP1096126
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $8.58万
  • 财政年份:
    2010
  • 负责人:
    Prof Richard Ivell
  • 依托单位:
Establishment of the endocrine axes in the embryo and their xenobiotic distortion
  • 批准号:
    DP0773315
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $22.64万
  • 财政年份:
    2007
  • 负责人:
    Prof Richard Ivell
  • 依托单位:
Male germ line transgenesis and siRNA technology for manipulating genes in domestic species
  • 批准号:
    LX0560258
  • 项目类别:
    Linkage - International
  • 资助金额:
    $10.29万
  • 财政年份:
    2005
  • 负责人:
    Prof Richard Ivell
  • 依托单位:
国内基金
海外基金
富含半胱氨酸分泌亚家族3蛋白与钙释放通道的相互作用
  • 批准号:
    30870508
  • 项目类别:
    面上项目
  • 资助金额:
    36.0万元
  • 批准年份:
    2008
  • 负责人:
    尹长城
  • 依托单位:
信号转导分子PAK4相互作用蛋白质的筛选
  • 批准号:
    30370736
  • 项目类别:
    面上项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2003
  • 负责人:
    李丰
  • 依托单位: